Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 253

1.

Bone tissue quality in patients with monoclonal gammopathy of uncertain significance.

Orduna G, Mellibovsky L, Abella E, Nogués X, Granero R, García-Giralt N, Pineda-Moncusí M, Güerri-Fernández R, Prieto-Alhambra D, Díez-Pérez A.

J Bone Miner Metab. 2020 Jan 23. doi: 10.1007/s00774-020-01084-3. [Epub ahead of print]

PMID:
31974675
2.

Oral Bisphosphonate Use and All-Cause Mortality in Patients With Moderate-Severe (Grade 3B-5D) Chronic Kidney Disease: A Population-Based Cohort Study.

Alarkawi D, Ali MS, Bliuc D, Pallares N, Tebe C, Elhussein L, Caskey FJ, Arden NK, Ben-Shlomo Y, Abrahamsen B, Diez-Perez A, Pascual J, Pérez-Sáez MJ, Center JR, Judge A, Cooper C, Javaid MK, Prieto-Alhambra D.

J Bone Miner Res. 2020 Jan 22. doi: 10.1002/jbmr.3961. [Epub ahead of print]

PMID:
31968134
3.

Bone material strength index is associated with prior fracture in men with and without moderate chronic kidney disease.

Holloway-Kew KL, Rufus-Membere P, Anderson KB, Betson A, Gaston J, Kotowicz MA, Diez-Perez A, Hyde NK, Pasco JA.

Bone. 2020 Jan 16;133:115241. doi: 10.1016/j.bone.2020.115241. [Epub ahead of print]

PMID:
31954850
4.

[Spanish National Hip Fracture Registry (RNFC): First-year results and comparison with other registries and prospective multi-centric studies from Spain].

Sáez-López P, Ojeda-Thies C, Alarcón T, Muñoz Pascual A, Mora-Fernández J, González de Villaumbrosia C, Molina Hernández MJ, Montero-Fernández N, Cancio Trujillo JM, Díez Pérez A, Prieto Alhambra D, Caeiro Rey JR, Etxebarria Foronda Í, Gómez Campelo P, Pareja Sierra T, Tarazona-Santabalbina FJ, López-Giménez R, Otero Puime Á, Navarro-Castellanos L, Queipo Matas R, Jiménez Mola S, López-Peña T, Cassinello Ogea C, González-Montalvo JI.

Rev Esp Salud Publica. 2019 Oct 18;93. pii: e201910072. Spanish.

5.

Increased Fracture Risk in Women Treated With Aromatase Inhibitors Versus Tamoxifen: Beneficial Effect of Bisphosphonates.

Pineda-Moncusí M, Garcia-Giralt N, Diez-Perez A, Servitja S, Tusquets I, Prieto-Alhambra D, Nogués X.

J Bone Miner Res. 2020 Feb;35(2):291-297. doi: 10.1002/jbmr.3886. Epub 2019 Oct 31.

PMID:
31596961
6.

The association between type 2 diabetes mellitus, hip fracture, and post-hip fracture mortality: a multi-state cohort analysis.

Tebé C, Martínez-Laguna D, Carbonell-Abella C, Reyes C, Moreno V, Diez-Perez A, Collins GS, Prieto-Alhambra D.

Osteoporos Int. 2019 Dec;30(12):2407-2415. doi: 10.1007/s00198-019-05122-3. Epub 2019 Aug 23.

PMID:
31444526
7.

Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis.

Lorentzon M, Branco J, Brandi ML, Bruyère O, Chapurlat R, Cooper C, Cortet B, Diez-Perez A, Ferrari S, Gasparik A, Herrmann M, Jorgensen NR, Kanis J, Kaufman JM, Laslop A, Locquet M, Matijevic R, McCloskey E, Minisola S, Pikner R, Reginster JY, Rizzoli R, Szulc P, Vlaskovska M, Cavalier E.

Adv Ther. 2019 Oct;36(10):2811-2824. doi: 10.1007/s12325-019-01063-9. Epub 2019 Aug 22.

8.

Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength: state of the art-outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

Diez-Perez A, Brandi ML, Al-Daghri N, Branco JC, Bruyère O, Cavalli L, Cooper C, Cortet B, Dawson-Hughes B, Dimai HP, Gonnelli S, Hadji P, Halbout P, Kaufman JM, Kurth A, Locquet M, Maggi S, Matijevic R, Reginster JY, Rizzoli R, Thierry T.

Aging Clin Exp Res. 2019 Oct;31(10):1375-1389. doi: 10.1007/s40520-019-01294-4. Epub 2019 Aug 17.

9.

Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF).

Hiligsmann M, Cornelissen D, Vrijens B, Abrahamsen B, Al-Daghri N, Biver E, Brandi ML, Bruyère O, Burlet N, Cooper C, Cortet B, Dennison E, Diez-Perez A, Gasparik A, Grosso A, Hadji P, Halbout P, Kanis JA, Kaufman JM, Laslop A, Maggi S, Rizzoli R, Thomas T, Tuzun S, Vlaskovska M, Reginster JY.

Osteoporos Int. 2019 Nov;30(11):2155-2165. doi: 10.1007/s00198-019-05104-5. Epub 2019 Aug 7.

10.

Associations Between Bone Impact Microindentation and Clinical Risk Factors for Fracture.

Rufus-Membere P, Holloway-Kew KL, Diez-Perez A, Kotowicz MA, Pasco JA.

Endocrinology. 2019 Sep 1;160(9):2143-2150. doi: 10.1210/en.2019-00415.

PMID:
31310275
11.

The impact of hip fracture on health-related quality of life and activities of daily living: the SPARE-HIP prospective cohort study.

Prieto-Alhambra D, Moral-Cuesta D, Palmer A, Aguado-Maestro I, Bardaji MFB, Brañas F, Bueno GA, Caeiro-Rey JR, Cano IA, Barres-Carsi M, Delgado LG, Salomó-Domènech M, Etxebarria-Foronda I, Ferrer BL, Mills S, Herrando LE, Mifsut D, Evangelista LDR, Nogués X, Perez-Coto I, Blasco JM, Martín-Hernández C, Kessel H, Serra JT, Solis JR, Suau OT, Vaquero-Cervino E, Hernández CP, Mañas LR, Herrera A, Díez-Perez A.

Arch Osteoporos. 2019 May 29;14(1):56. doi: 10.1007/s11657-019-0607-0.

12.

Assessment of early therapy discontinuation and health-related quality of life in breast cancer patients treated with aromatase inhibitors: B-ABLE cohort study.

Pineda-Moncusí M, Servitja S, Tusquets I, Diez-Perez A, Rial A, Cos ML, Campodarve I, Rodriguez-Morera J, Garcia-Giralt N, Nogués X.

Breast Cancer Res Treat. 2019 Aug;177(1):53-60. doi: 10.1007/s10549-019-05289-7. Epub 2019 May 24.

PMID:
31127467
13.

Spanish National Hip Fracture Registry (RNFC): analysis of its first annual report and international comparison with other established registries.

Ojeda-Thies C, Sáez-López P, Currie CT, Tarazona-Santalbina FJ, Alarcón T, Muñoz-Pascual A, Pareja T, Gómez-Campelo P, Montero-Fernández N, Mora-Fernández J, Larrainzar-Garijo R, Gil-Garay E, Etxebarría-Foronda I, Caeiro JR, Díez-Pérez A, Prieto-Alhambra D, Navarro-Castellanos L, Otero-Puime A, González-Montalvo JI; participants in the RNFC.

Osteoporos Int. 2019 Jun;30(6):1243-1254. doi: 10.1007/s00198-019-04939-2. Epub 2019 Mar 23.

PMID:
30904929
14.

Functional characterization of the C7ORF76 genomic region, a prominent GWAS signal for osteoporosis in 7q21.3.

Roca-Ayats N, Martínez-Gil N, Cozar M, Gerousi M, Garcia-Giralt N, Ovejero D, Mellibovsky L, Nogués X, Díez-Pérez A, Grinberg D, Balcells S.

Bone. 2019 Jun;123:39-47. doi: 10.1016/j.bone.2019.03.014. Epub 2019 Mar 14.

PMID:
30878523
15.

Inflammation status in HIV-positive individuals correlates with changes in bone tissue quality after initiation of ART.

Lerma-Chippirraz E, Pineda-Moncusí M, González-Mena A, Soldado-Folgado J, Knobel H, Trenchs-Rodríguez M, Díez-Pérez A, Brown TT, García-Giralt N, Güerri-Fernández R.

J Antimicrob Chemother. 2019 May 1;74(5):1381-1388. doi: 10.1093/jac/dkz014.

PMID:
30768163
16.

Proof of Concept on Functionality Improvement of Mesenchymal Stem-Cells, in Postmenopausal Osteoporotic Women Treated with Teriparatide (PTH1-34), After Suffering Atypical Fractures.

Casado-Díaz A, Dorado G, Giner M, Montoya MJ, Navarro-Valverde C, Díez-Pérez A, Quesada-Gómez JM.

Calcif Tissue Int. 2019 Jun;104(6):631-640. doi: 10.1007/s00223-019-00533-0. Epub 2019 Feb 6.

PMID:
30725167
17.

Circulating miR-103a-3p and miR-660-5p are associated with bone parameters in patients with controlled acromegaly.

Valassi E, García-Giralt N, Malouf J, Crespo I, Llauger J, Díez-Pérez A, Webb SM.

Endocr Connect. 2019 Jan 1;8(1):39-49. doi: 10.1530/EC-18-0482.

18.

Feasibility and tolerability of bone impact microindentation testing: a cross-sectional, population-based study in Australia.

Rufus-Membere P, Holloway-Kew KL, Diez-Perez A, Kotowicz MA, Pasco JA.

BMJ Open. 2018 Dec 22;8(12):e023959. doi: 10.1136/bmjopen-2018-023959.

19.

Pro-osteoporotic miR-320a impairs osteoblast function and induces oxidative stress.

De-Ugarte L, Balcells S, Nogues X, Grinberg D, Diez-Perez A, Garcia-Giralt N.

PLoS One. 2018 Nov 28;13(11):e0208131. doi: 10.1371/journal.pone.0208131. eCollection 2018.

20.

Effects of teriparatide on hip and upper limb fractures in patients with osteoporosis: A systematic review and meta-analysis.

Díez-Pérez A, Marin F, Eriksen EF, Kendler DL, Krege JH, Delgado-Rodríguez M.

Bone. 2019 Mar;120:1-8. doi: 10.1016/j.bone.2018.09.020. Epub 2018 Sep 27.

21.

Vitamin D levels in Mediterranean breast cancer patients compared with those in healthy women.

Pineda-Moncusí M, Garcia-Perez MA, Rial A, Casamayor G, Cos ML, Servitja S, Tusquets I, Diez-Perez A, Cano A, Garcia-Giralt N, Nogues X.

Maturitas. 2018 Oct;116:83-88. doi: 10.1016/j.maturitas.2018.07.015. Epub 2018 Jul 29.

PMID:
30244785
22.

Bone health evaluation one year after aromatase inhibitors completion.

Pineda-Moncusí M, Servitja S, Casamayor G, Cos ML, Rial A, Rodriguez-Morera J, Tusquets I, Diez-Perez A, Garcia-Giralt N, Nogués X.

Bone. 2018 Dec;117:54-59. doi: 10.1016/j.bone.2018.09.010. Epub 2018 Sep 14.

PMID:
30223134
23.

In-hospital care, complications, and 4-month mortality following a hip or proximal femur fracture: the Spanish registry of osteoporotic femur fractures prospective cohort study.

Prieto-Alhambra D, Reyes C, Sainz MS, González-Macías J, Delgado LG, Bouzón CA, Gañan SM, Miedes DM, Vaquero-Cervino E, Bardaji MFB, Herrando LE, Baztán FB, Ferrer BL, Perez-Coto I, Bueno GA, Mora-Fernandez J, Doñate TE, Blasco JM, Aguado-Maestro I, Sáez-López P, Doménech MS, Climent-Peris V, Rodríguez ÁD, Sardiñas HK, Gómez ÓT, Serra JT, Caeiro-Rey JR, Cano IA, Carsi MB, Etxebarria-Foronda I, Hernández JDA, Solis JR, Suau OT, Nogués X, Herrera A, Díez-Perez A.

Arch Osteoporos. 2018 Sep 14;13(1):96. doi: 10.1007/s11657-018-0515-8.

24.

Fracture risk in type 2 diabetic patients: A clinical prediction tool based on a large population-based cohort.

Martínez-Laguna D, Tebé C, Nogués X, Kassim Javaid M, Cooper C, Moreno V, Diez-Perez A, Collins GS, Prieto-Alhambra D.

PLoS One. 2018 Sep 7;13(9):e0203533. doi: 10.1371/journal.pone.0203533. eCollection 2018.

25.

Functional Characterization of a GGPPS Variant Identified in Atypical Femoral Fracture Patients and Delineation of the Role of GGPPS in Bone-Relevant Cell Types.

Roca-Ayats N, Ng PY, Garcia-Giralt N, Falcó-Mascaró M, Cozar M, Abril JF, Quesada Gómez JM, Prieto-Alhambra D, Nogués X, Dunford JE, Russell RG, Baron R, Grinberg D, Balcells S, Díez-Pérez A.

J Bone Miner Res. 2018 Dec;33(12):2091-2098. doi: 10.1002/jbmr.3580. Epub 2018 Sep 24.

26.

Maintenance low dose systemic glucocorticoids have limited impact on bone strength and mineral density among incident renal allograft recipients: A pilot prospective cohort study.

Pérez-Sáez MJ, Herrera S, Prieto-Alhambra D, Vilaplana L, Nogués X, Vera M, Redondo-Pachón D, Mir M, Güerri R, Crespo M, Díez-Pérez A, Pascual J.

Bone. 2018 Nov;116:290-294. doi: 10.1016/j.bone.2018.08.013. Epub 2018 Aug 23.

PMID:
30145341
27.

Common and rare variants of WNT16, DKK1 and SOST and their relationship with bone mineral density.

Martínez-Gil N, Roca-Ayats N, Monistrol-Mula A, García-Giralt N, Díez-Pérez A, Nogués X, Mellibovsky L, Grinberg D, Balcells S.

Sci Rep. 2018 Jul 19;8(1):10951. doi: 10.1038/s41598-018-29242-8.

28.

Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case-control study.

Losada E, Soldevila B, Ali MS, Martínez-Laguna D, Nogués X, Puig-Domingo M, Díez-Pérez A, Mauricio D, Prieto-Alhambra D.

Osteoporos Int. 2018 Sep;29(9):2079-2086. doi: 10.1007/s00198-018-4581-y. Epub 2018 Jun 2.

PMID:
29860664
29.

Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study.

McClung MR, Brown JP, Diez-Perez A, Resch H, Caminis J, Meisner P, Bolognese MA, Goemaere S, Bone HG, Zanchetta JR, Maddox J, Bray S, Grauer A.

J Bone Miner Res. 2018 Aug;33(8):1397-1406. doi: 10.1002/jbmr.3452. Epub 2018 May 22.

30.

Differential Mortality and the Excess Rates of Hip Fracture Associated With Type 2 Diabetes: Accounting for Competing Risks in Fracture Prediction Matters.

Tebé C, Martinez-Laguna D, Moreno V, Cooper C, Diez-Perez A, Collins GS, Prieto-Alhambra D.

J Bone Miner Res. 2018 Aug;33(8):1417-1421. doi: 10.1002/jbmr.3435. Epub 2018 May 3.

31.

Spanish National Hip Fracture Registry (SNHFR): a description of its objectives, methodology and implementation.

Sáez-López P, González-Montalvo JI, Ojeda-Thies C, Mora-Fernández J, Muñoz-Pascual A, Cancio JM, Tarazona FJ, Pareja T, Gómez-Campelo P, Montero-Fernández N, Alarcón T, Mesa-Lampre P, Larrainzar-Gar R, Duaso E, Gil-Garay E, Diéz-Pérez A, Prieto-Alhambra D, Queipo-Matas R, Otero-Puime A; participants in the RNFC.

Rev Esp Geriatr Gerontol. 2018 Jul - Aug;53(4):188-195. doi: 10.1016/j.regg.2017.12.001. Epub 2018 Feb 14.

PMID:
29426794
32.

Bone density, microarchitecture, and tissue quality after 1 year of treatment with tenofovir disoproxil fumarate.

Güerri-Fernández R, Lerma-Chippirraz E, Fernandez Marron A, García-Giralt N, Villar-García J, Soldado-Folgado J, González-Mena A, Trenchs-Rodríguez M, Guelar A, Díez-Pérez A, Brown TT, Knobel H.

AIDS. 2018 Apr 24;32(7):913-920. doi: 10.1097/QAD.0000000000001780.

PMID:
29424785
33.

Validation of fragility fractures in primary care electronic medical records: A population-based study.

Martinez-Laguna D, Soria-Castro A, Carbonell-Abella C, Orozco-López P, Estrada-Laza P, Nogues X, Díez-Perez A, Prieto-Alhambra D.

Reumatol Clin. 2019 Sep - Oct;15(5):e1-e4. doi: 10.1016/j.reuma.2017.10.013. Epub 2017 Nov 28. English, Spanish.

34.

Advances in the evaluation of bone health in kidney transplant patients.

Pérez-Sáez MJ, Prieto-Alhambra D, Díez-Pérez A, Pascual J.

Nefrologia. 2018 Jan - Feb;38(1):27-33. doi: 10.1016/j.nefro.2017.04.002. Epub 2017 Nov 11. Review. English, Spanish.

35.

Expression profiling of microRNAs in human bone tissue from postmenopausal women.

De-Ugarte L, Serra-Vinardell J, Nonell L, Balcells S, Arnal M, Nogues X, Mellibovsky L, Grinberg D, Diez-Perez A, Garcia-Giralt N.

Hum Cell. 2018 Jan;31(1):33-41. doi: 10.1007/s13577-017-0181-y. Epub 2017 Sep 20.

PMID:
28933035
36.

Self-perception of fracture risk: what can it tell us?

Litwic AE, Compston JE, Wyman A, Siris ES, Gehlbach SH, Adachi JD, Chapurlat R, Díez-Pérez A, LaCroix AZ, Nieves JW, Netelenbos JC, Pfeilschifter J, Rossini M, Roux C, Saag KG, Silverman S, Watts NB, Greenspan SL, March L, Gregson CL, Cooper C, Dennison EM; Global Longitudinal Study of Osteoporosis in Women (GLOW) Investigators.

Osteoporos Int. 2017 Dec;28(12):3495-3500. doi: 10.1007/s00198-017-4200-3. Epub 2017 Aug 31.

37.

Discrepancy between bone density and bone material strength index in three siblings with Camurati-Engelmann disease.

Herrera S, Soriano R, Nogués X, Güerri-Fernandez R, Grinberg D, García-Giralt N, Martínez-Gil N, Castejón S, González-Lizarán A, Balcells S, Diez-Perez A.

Osteoporos Int. 2017 Dec;28(12):3489-3493. doi: 10.1007/s00198-017-4198-6. Epub 2017 Aug 25.

PMID:
28842728
38.

Excess of all-cause mortality after a fracture in type 2 diabetic patients: a population-based cohort study.

Martinez-Laguna D, Nogues X, Abrahamsen B, Reyes C, Carbonell-Abella C, Diez-Perez A, Prieto-Alhambra D.

Osteoporos Int. 2017 Sep;28(9):2573-2581. doi: 10.1007/s00198-017-4096-y. Epub 2017 Jul 25.

PMID:
28744600
39.

Cortical and Trabecular Bone Analysis of Patients With High Bone Mass From the Barcelona Osteoporosis Cohort Using 3-Dimensional Dual-Energy X-ray Absorptiometry: A Case-Control Study.

Orduna G, Humbert L, Fonolla R, Romera J, Cos ML, Rial A, Nogués X, Diez-Perez A, Mellibovsky L.

J Clin Densitom. 2018 Oct - Dec;21(4):480-484. doi: 10.1016/j.jocd.2017.05.012. Epub 2017 Jun 22.

PMID:
28648836
40.

Insulin use and Excess Fracture Risk in Patients with Type 2 Diabetes: A Propensity-Matched cohort analysis.

Losada-Grande E, Hawley S, Soldevila B, Martinez-Laguna D, Nogues X, Diez-Perez A, Puig-Domingo M, Mauricio D, Prieto-Alhambra D.

Sci Rep. 2017 Jun 19;7(1):3781. doi: 10.1038/s41598-017-03748-z.

41.

Erratum to: MiRNA profiling of whole trabecular bone: identification of osteoporosis-related changes in MiRNAs in human hip bones.

De-Ugarte L, Yoskovitz G, Balcells S, Güerri-Fernández R, Martinez-Diaz S, Mellibovsky L, Urreizti R, Nogués X, Grinberg D, García-Giralt N, Díez-Pérez A.

BMC Med Genomics. 2017 May 23;10(1):36. doi: 10.1186/s12920-017-0272-3. No abstract available.

42.

Bone density, microarchitecture, and material strength in chronic kidney disease patients at the time of kidney transplantation.

Pérez-Sáez MJ, Herrera S, Prieto-Alhambra D, Vilaplana L, Nogués X, Vera M, Redondo-Pachón D, Mir M, Güerri R, Crespo M, Díez-Pérez A, Pascual J.

Osteoporos Int. 2017 Sep;28(9):2723-2727. doi: 10.1007/s00198-017-4065-5. Epub 2017 May 11.

PMID:
28497224
43.

GGPS1 Mutation and Atypical Femoral Fractures with Bisphosphonates.

Roca-Ayats N, Balcells S, Garcia-Giralt N, Falcó-Mascaró M, Martínez-Gil N, Abril JF, Urreizti R, Dopazo J, Quesada-Gómez JM, Nogués X, Mellibovsky L, Prieto-Alhambra D, Dunford JE, Javaid MK, Russell RG, Grinberg D, Díez-Pérez A.

N Engl J Med. 2017 May 4;376(18):1794-1795. doi: 10.1056/NEJMc1612804. No abstract available.

PMID:
28467865
44.

Bone Density, Microarchitecture, and Tissue Quality After Long-Term Treatment With Tenofovir/Emtricitabine or Abacavir/Lamivudine.

Güerri-Fernández R, Molina-Morant D, Villar-García J, Herrera S, González-Mena A, Guelar A, Trenchs-Rodríguez M, Díez-Pérez A, Knobel H.

J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):322-327. doi: 10.1097/QAI.0000000000001396.

PMID:
28418990
45.

Patients' preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment.

Hiligsmann M, Dellaert BG, Dirksen CD, Watson V, Bours S, Goemaere S, Reginster JY, Roux C, McGowan B, Silke C, Whelan B, Diez-Perez A, Torres E, Papadakis G, Rizzoli R, Cooper C, Pearson G, Boonen A.

Rheumatology (Oxford). 2017 Jul 1;56(7):1167-1176. doi: 10.1093/rheumatology/kex071.

46.

Presence of pyrophosphate in bone from an atypical femoral fracture site: A case report.

Shabestari M, Eriksen EF, Paschalis EP, Roschger P, Gamsjaeger S, Klaushofer K, Berzlanovich A, Nogues X, Puig L, Diez-Perez A.

Bone Rep. 2017 Mar 2;6:81-86. doi: 10.1016/j.bonr.2017.02.006. eCollection 2017 Jun.

47.

SNPs in bone-related miRNAs are associated with the osteoporotic phenotype.

De-Ugarte L, Caro-Molina E, Rodríguez-Sanz M, García-Pérez MA, Olmos JM, Sosa-Henríquez M, Pérez-Cano R, Gómez-Alonso C, Del Rio L, Mateo-Agudo J, Blázquez-Cabrera JA, González-Macías J, Pino-Montes JD, Muñoz-Torres M, Diaz-Curiel M, Malouf J, Cano A, Pérez-Castrillon JL, Nogues X, Garcia-Giralt N, Diez-Perez A.

Sci Rep. 2017 Mar 31;7(1):516. doi: 10.1038/s41598-017-00641-7.

48.

Recommendations for the screening of adherence to oral bisphosphonates: reply to comments by Zhou and Sheng.

Eastell R, Diez-Perez A.

Osteoporos Int. 2017 Jul;28(7):2257-2258. doi: 10.1007/s00198-017-3991-6. Epub 2017 Mar 10. No abstract available.

PMID:
28283689
49.

Assessment of Bone Health in Patients With Type 1 Gaucher Disease Using Impact Microindentation.

Herrera S, Pérez-López J, Moltó-Abad M, Güerri-Fernández R, Cabezudo E, Novelli S, Esteve J, Hernández A, Roig I, Solanich X, Prieto-Alhambra D, Nogués X, Díez-Pérez A.

J Bone Miner Res. 2017 Jul;32(7):1575-1581. doi: 10.1002/jbmr.3121. Epub 2017 May 11.

50.

International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates.

Diez-Perez A, Naylor KE, Abrahamsen B, Agnusdei D, Brandi ML, Cooper C, Dennison E, Eriksen EF, Gold DT, Guañabens N, Hadji P, Hiligsmann M, Horne R, Josse R, Kanis JA, Obermayer-Pietsch B, Prieto-Alhambra D, Reginster JY, Rizzoli R, Silverman S, Zillikens MC, Eastell R; Adherence Working Group of the International Osteoporosis Foundation and the European Calcified Tissue Society.

Osteoporos Int. 2017 Mar;28(3):767-774. doi: 10.1007/s00198-017-3906-6. Epub 2017 Jan 16.

Supplemental Content

Loading ...
Support Center